Valvular & structural heart disease

Mixed aortic valve disease: association with paravalvular leak and reduced survival after transcatheter aortic valve replacement

Eur Heart J Cardiovasc ImagingPublished Registry-based cohort study

Main finding · PVRResult — go to the resultOdds ratio 2.06 95% CI 1.51–2.81

Authors' conclusion

MAVD is prevalent among TAVR patients and presents unique challenges, with increased PVR risk and worse outcomes compared with isolated AS. Long-term survival for MAVD patients, not limited to those developing PVR post-TAVR, is compromised.

Study context

Population
Patients undergoing transcatheter aortic valve replacement (TAVR) at Medical University of Vienna, January 2007–May 2020, with TTE before and after TAVRVienna TAVR registry
Participants
880 patients
Exposure
Mixed aortic valve disease (MAVD) vs isolated aortic stenosis (AS)
  • MAVDn = 647
Outcome
Prevalence of MAVD, association with paravalvular regurgitation (PVR), and long-term mortality after TAVR
Methodological detailssingle-centre
  • Single-centre

Main finding

PVR

Odds ratio

2.06

95% CI 1.51–2.81

P = <0.001

Events by group

MAVD

73.52%

647

MAVDvs Isolated AS
OR 2.06 (95% CI 1.51–2.81); P = <0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Mortality with more than mild PVR after TAVRvs no PVRMore than mild PVR in 168 of 880 (19.09%)1.33 (1.05–1.67)P = 0.016
Mortality in MAVD with ≥ mild PVR after TAVRvs no PVR (subgroup)1.30 (1.04–1.62)P = 0.022

Original publication

Mixed aortic valve disease: association with paravalvular leak and reduced survival after transcatheter aortic valve replacement. Eur Heart J Cardiovasc Imaging. Published 17 January 2024. doi:10.1093/ehjci/jeae005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.